We are live on ! Find out more
LAB icon

Standard BioTools
LAB

144 hedge funds and large institutions have $480M invested in Standard BioTools in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,045% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $110K

11% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 35

3% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 34

1% less funds holding

Funds holding: 145 → 144 (-1)

18.23% less ownership

Funds ownership: 91.46% → 73.23% (-18%)

33% less capital invested

Capital invested by funds: $719M → $480M (-$239M)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
144
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
2.08%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
35
Increased
39
Reduced
35
Closed
34
Calls
$1.26M
Puts
$110K
Net Calls
+$1.15M
Net Calls Change
-$1.96M

Top Buyers

1
BlackRock
BlackRock
New York
+$39.8M
2
Morgan Stanley
Morgan Stanley
New York
+$13M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.99M
4
State Street
State Street
Massachusetts
+$7.32M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$7.26M

Top Sellers

1
ICM
Indaba Capital Management
California
-$20M
2
Millennium Management
Millennium Management
New York
-$19.9M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.4M
4
Goldman Sachs
Goldman Sachs
New York
-$6.44M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
151
ExodusPoint Capital Management
New York
– -$825K -304,495 Closed
PAS
152
Point72 Asia (Singapore)
Singapore
– -$822K -303,213 Closed
LCM
153
Laurion Capital Management
New York
– -$813K -300,010 Closed
MFS
154
Mirabella Financial Services
United Kingdom
– -$584K -215,520 Closed
BCM
155
Bridgeway Capital Management
Texas
– -$575K -212,000 Closed
JF
156
Jump Financial
Illinois
– -$574K -211,893 Closed
Point72 Asset Management
157
Point72 Asset Management
Connecticut
– -$386K -142,300 Closed
JFG
158
Jefferies Financial Group
New York
– -$324K -119,400 Closed
BHCM
159
Brevan Howard Capital Management
Jersey
– -$317K -116,905 Closed
YIH
160
Y-Intercept (HK)
Hong Kong
– -$300K -110,882 Closed
LM
161
Luminus Management
Texas
– -$257K -95,000 Closed
FCM
162
FourWorld Capital Management
New York
– -$249K -91,700 Closed
DM
163
Deerfield Management
New York
– -$212K -78,090 Closed
CAS
164
CTC Alternative Strategies
Illinois
– -$156K -57,600 Closed
EGM
165
Engineers Gate Manager
New York
– -$123K -45,383 Closed
OAC
166
OMERS Administration Corp
Ontario, Canada
– -$101K -37,400 Closed
DS
167
DRW Securities
Illinois
– -$82.9K -30,600 Closed
TRCT
168
Tower Research Capital (TRC)
New York
– -$72.6K -26,803 Closed
PCMH
169
Polymer Capital Management (HK)
Hong Kong
– -$62.3K -23,000 Closed
CGIM
170
Cannon Global Investment Management
Florida
– -$54.2K -20,000 Closed
Macquarie Group
171
Macquarie Group
Australia
– -$53 -19,608 Closed
SI
172
Symmetry Investments
Jersey
– -$51.5K -19,000 Closed
MHC
173
Meyer Handelman Company
New York
– -$47.4K -17,500 Closed
TC
174
TradeLink Capital
Illinois
– -$47K -17,300 Closed
PAM
175
Peak Asset Management
Colorado
– -$45.6K -16,841 Closed
4 5 6
7
8

LAB Hedge Fund Activity: Q2 2024 in Review

144 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q2 2024, worth a combined $480M — down 33% from $719M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new LAB positions and 34 closed out — a net gain of 1 holder — while 39 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock, adding an estimated $39.8M. The largest seller was Indaba Capital Management, exiting entirely with an estimated $20M sold.

  • 144 institutional investors held Standard BioTools (LAB) as of Q2 2024, down from 145 in Q1 2024.
  • Funds reported $480M of Standard BioTools stock for Q2 2024, down 33% quarter-over-quarter.
  • 35 funds opened new Standard BioTools positions in Q2 2024 and 34 closed out, a net change of +1 holder.
  • The largest Standard BioTools buyer in Q2 2024 was BlackRock, an estimated $39.8M added.
  • The largest Standard BioTools seller in Q2 2024 was Indaba Capital Management, an estimated $20M sold.

Based on aggregated 13F filings for Q2 2024.